Gudesblatt, M., Wissemann, K., Zarif, M., Bumstead, B., Fafard, L., Wilken, J., . . . Lee, L. (2018). Correction to: Improvement in Cognitive Function as Measured by NeuroTrax in Patients with Relapsing Multiple Sclerosis Treated with Natalizumab: A 2-Year Retrospective Analysis. CNS Drugs.
शिकागो स्टाइल उद्धरणGudesblatt, Mark, et al. "Correction To: Improvement in Cognitive Function As Measured By NeuroTrax in Patients With Relapsing Multiple Sclerosis Treated With Natalizumab: A 2-Year Retrospective Analysis." CNS Drugs 2018.
एमएलए उद्धरणGudesblatt, Mark, et al. "Correction To: Improvement in Cognitive Function As Measured By NeuroTrax in Patients With Relapsing Multiple Sclerosis Treated With Natalizumab: A 2-Year Retrospective Analysis." CNS Drugs 2018.